Einträge von Perl, Markus auf dem Publikationsserver

Scheiter, Alexander , Mellin, Simon, Keil, Felix , Meier, Johannes, Heudobler, Daniel , Brummer, Christina, Einhell, Sabine , Zwicker, Benjamin, Wutzlhofer, Elena, Hierl, Frederik, Klemm, Sophie, Lüftl, Elena, Schneider, Tom, Perl, Markus, Klier-Richter, Margit, Immel, Alexander, Kaltofen, Till , Grube, Matthias, Bumes, Elisabeth , Seitz, Stephan, Schulz, Christian , Haferkamp, Sebastian , Drexler, Konstantin , Troeger, Anja, Steger, Felix, Schlosser-Hupf, Sophie, Tews, Hauke Christian, Kandulski, Arne , Wohlfart, Kristina, Erber, Ramona , Schönbuchner, Ines, Lessel, Davor , Schnabel, Marco J., Sedlmeier, Anja M. , Klinkhammer-Schalke, Monika, Maurer, Julia , Calvisi, Diego F. , Pukrop, Tobias , Kaiser, Ulrich , Hirsch, Daniela, Dietmaier, Wolfgang, Evert, Matthias, Lüke, Florian und Utpatel, Kirsten (2026) Supplementary biomarker testing in molecular tumor boards increases actionable therapy recommendations: a prospective real-world study of 658 patients. BMC Medicine 24 (1).

Göttert, Sascha, Thiele Orberg, Erik , Fan, Kaiji, Heinrich, Paul , Matthe, Diana M., Khalid, Omer, Klostermeier, Lena, Suriano, Chiara, Strieder, Nicholas , Gebhard, Claudia , Vonbrunn, Eva, Mamilos, Andreas , Hirsch, Daniela, Meedt, Elisabeth, Kleigrewe, Karin, Hiergeist, Andreas , Schwarz, Alix, Gläsner, Joachim, Ghimire, Sakhila, Joachim, Laura, Voll, Florian, Neuhaus, Klaus, Janssen, Klaus-Peter, Perl, Markus, Pielmeier, Franziska, Ruland, Jürgen, Kreutz, Marina , Weber, Daniela, Schmidl, Christian , Köhler, Natalie, Tschurtschenthaler, Markus, Hoffmann, Petra, Edinger, Matthias , Wolff, Daniel , Bassermann, Florian, Rehli, Michael , Haller, Dirk, Evert, Matthias, Hildner, Kai, Büttner-Herold, Maike, Herr, Wolfgang, Gessner, André , Heidegger, Simon, Holler, Ernst und Poeck, Hendrik (2025) The microbial metabolite desaminotyrosine protects against graft-versus-host disease via mTORC1 and STING-dependent intestinal regeneration. Nature Communications 16 (1).

Hansmann, Helena, Henkel, Chiara, Fante, Matthias A. , Harrer, Dennis C. , Heidemanns, Stefanie , Oellerich, Michael, Beck, Julia, Schütz, Ekkehard, Biswenger, Verena, Perl, Markus, Zartner, Barbara, Edinger, Matthias , Wolff, Daniel , Hoffmann, Petra, Herr, Wolfgang, Banas, Bernhard , Zecher, Daniel und Hansmann, Leo (2025) Sustained allogeneic kidney graft operational tolerance despite discontinued conventional immunosuppression after CD19-CAR-T cell therapy for relapsed/refractory posttransplant lymphoproliferative disorder. American Journal of Transplantation 26 (2), S. 340-348.

Perl, Markus, Fante, Matthias A. , Herfeld, Konstantin, Scherer, Julian N., Poeck, Hendrik und Thiele Orberg, Erik (2025) Microbiota-derived metabolites: Key modulators of cancer immunotherapies. Med 6 (8), S. 100773.

Heidenreich, Silke, Egger-Heidrich, Katharina, Halter, Jörg P., Jost, Lasse, Stölzel, Friedrich, Perl, Markus, Denk, Alexander , Edinger, Matthias , Herr, Wolfgang, Kröger, Nicolaus, Wolff, Daniel , Ayuk, Francis und Fante, Matthias A. (2025) Safety and efficacy of the ROCK-2-inhibitor Belumosudil in cGvHD treatment - a retrospective, German-Swiss multicenter real-world data analysis. Bone Marrow Transplantation.

Knoedler, Leonard , Huelsboemer, Lioba, Hollmann, Katharina, Alfertshofer, Michael, Herfeld, Konstantin, Hosseini, Helia, Boroumand, Sam, Stoegner, Viola A., Safi, Ali-Farid, Perl, Markus, Knoedler, Samuel , Pomahac, Bohdan und Kauke-Navarro, Martin (2024) From standard therapies to monoclonal antibodies and immune checkpoint inhibitors – an update for reconstructive surgeons on common oncological cases. Frontiers in Immunology 15.

Perl, Markus, Herfeld, Konstantin, Harrer, Dennis C. , Höpting, Matthias, Schweiger, Marina, Sterz, Ulrich, Knödler, Leonard, Heimerl, Susanne, Hansmann, Leo , Herr, Wolfgang, Poeck, Hendrik, Wolff, Daniel , Edinger, Matthias, Hart, Christina und Fante, Matthias Alexander (2024) Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies. Haematologica.

Heidegger, Simon , Stritzke, Florian, Dahl, Sarah, Daßler-Plenker, Juliane, Joachim, Laura, Buschmann, Dominik, Fan, Kaiji, Sauer, Carolin M., Ludwig, Nils, Winter, Christof, Enssle, Stefan, Li, Suqi, Perl, Markus, Görgens, André, Haas, Tobias, Orberg, Erik Thiele, Göttert, Sascha, Wölfel, Catherine, Engleitner, Thomas, Cortés-Ciriano, Isidro, Rad, Roland, Herr, Wolfgang, Giebel, Bernd, Ruland, Jürgen , Bassermann, Florian, Coch, Christoph, Hartmann, Gunther und Poeck, Hendrik (2023) Targeting nucleic acid sensors in tumor cells to reprogram biogenesis and RNA cargo of extracellular vesicles for T cell-mediated cancer immunotherapy. Cell Reports Medicine, S. 101171.

Doering, Jana, Perl, Markus, Weber, Daniela, Banas, Bernhard, Schulz, Christian, Hamer, Okka W., Angstwurm, Klemens, Holler, Ernst, Herr, Wolfgang, Edinger, Matthias, Wolff, Daniel und Fante, Matthias A. (2023) Incidence and Outcome of Atypical Manifestations of Chronic Graft-versus-Host Disease: Results From a Retrospective Single-Center Analysis. Transplantation and Cellular Therapy 29 (12), 772.e1-772.e10. Volltext nicht vorhanden.

Knoedler, Leonard, Oezdemir, Berkin, Moog, Philipp, Prantl, Lukas , Broer, P. Niclas, Knoedler, Christoph, Rieger, Ulrich M., Perl, Markus, von Isenburg, Sarah, Gassner, Ulrich M., Obed, Doha, Haug, Valentin, Panayi, Adriana C. und Knoedler, Samuel (2023) Thinking like a Lawyer—Human Rights and Their Association with the Plastic Surgeon of Today. Aesthetic Plastic Surgery 47 (1), S. 490-497. Volltext nicht vorhanden.

Ecker, Josef , Benedetti, Elisa, Kindt, Alida S.D., Höring, Marcus, Perl, Markus, Machmüller, Andrea Christel, Sichler, Anna, Plagge, Johannes , Wang, Yuting, Zeissig, Sebastian , Shevchenko, Andrej, Burkhardt, Ralph , Krumsiek, Jan, Liebisch, Gerhard und Janssen, Klaus-Peter (2021) The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature. Gastroenterology 161 (3), 910-923.e19. Volltext nicht vorhanden.